![]() |
|
searchpremium serviceseventsdirectory servicesadvertisingcustomer care |
Chemical Week Magazine :: Business & Finance :: Europe/Mideast Solvay Sets €3-Billion Ebitda Target Post Rhodia Acquisition7:26 AM MDT | April 27, 2012 | —Natasha Alperowicz Clamadieu: Double-digit growth. Solvay has outlined profitability targets for 2016 as part of the group’s planned transformation following the acquisition of Rhodia seven months ago. Jean-Pierre Clamadieu, who will become Solvay’s CEO on May 11, announced the company’s ambitions at a capital markets day, held in London last week. These include reaching €3 billion ($3.94 billion) in recurring Ebitda (Rebitda) in 2016, compared with €2.07 billion in 2011; additional savings targets; and prioritizing the group’s most lucrative... This information is only available to Chemical Week subscribers. Forgot your user ID or password?
|
Not an IHS Chemical Week
|
Connect with IHS Chemical Week |
Quick links |
Our related sites |
|
contact us | about us |
customer care |
privacy policy |
sitemap |
advertise
|